Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome | Zendy

Yaseen M. Arabi | Zendy; Ayed Y. Asiri | Zendy; Abdullah M. Assiri | Zendy; Hanan H. Balkhy | Zendy; Ali Al Bshabshe | Zendy; Majed Al Jeraisy | Zendy; Yasser Mandourah | Zendy; Mohamed H. Azzam | Zendy; Abdulhadi M. Bin Eshaq | Zendy; Sameera Al Johani | Zendy; Shmeylan Al Harbi | Zendy; Hani Jokhdar | Zendy; Ahmad Deeb | Zendy; Ziad A. Memish | Zendy; Jesna Jose | Zendy; Sameeh Ghazal | Zendy; Sarah Al Faraj | Zendy; Ghaleb A. Al Mekhlafi | Zendy; Nisreen Murad Sherbeeni | Zendy; Fatehi Elzein | Zendy; Fahad Al-Hameed | Zendy; Asim Al Saedi | Zendy; Naif Khalaf Alharbi | Zendy; Robert Fowler | Zendy; Frederick G. Hayden | Zendy; Abdulaziz AlDawood | Zendy; M. A. Abdelzaher | Zendy; Wail Bajhmom | Zendy; Badriah M. AlMutairi | Zendy; Mohamed Hussein | Zendy; Adel Alothman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome

Author(s) -

Yaseen M. Arabi,

Ayed Y. Asiri,

Abdullah M. Assiri,

Hanan H. Balkhy,

Ali Al Bshabshe,

Majed Al Jeraisy,

Yasser Mandourah,

Mohamed H. Azzam,

Abdulhadi M. Bin Eshaq,

Sameera Al Johani,

Shmeylan Al Harbi,

Hani Jokhdar,

Ahmad Deeb,

Ziad A. Memish,

Jesna Jose,

Sameeh Ghazal,

Sarah Al Faraj,

Ghaleb A. Al Mekhlafi,

Nisreen Murad Sherbeeni,

Fatehi Elzein,

Fahad Al-Hameed,

Asim Al Saedi,

Naif Khalaf Alharbi,

Robert Fowler,

Frederick G. Hayden,

Abdulaziz AlDawood,

M. A. Abdelzaher,

Wail Bajhmom,

Badriah M. AlMutairi,

Mohamed Hussein,

Adel Alothman

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2015294

Subject(s) - lopinavir , ritonavir , lopinavir/ritonavir , middle east respiratory syndrome , medicine , virology , middle east respiratory syndrome coronavirus , immunology , covid-19 , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , disease , infectious disease (medical specialty)

Whether combined treatment with recombinant interferon beta-1b and lopinavir-ritonavir reduces mortality among patients hospitalized with Middle East respiratory syndrome (MERS) is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research